Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders
- PMID: 24023269
- DOI: 10.1136/jnnp-2013-305549
Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders
Abstract
Objective: To investigate the extrastriatal dopaminergic neural changes in relation to the medication-related impulse control disorders (ICD) in Parkinson's disease (PD).
Method: A total of 31 subjects (11 and 11 drug-treated PD patients with and without medication-related ICDs and 9 healthy controls) having no other co-morbid psychiatric disorders participated in this study. Each subject underwent dynamic N-(3-[(18)F]fluoropropyl)-2-carbomethoxy-3-(4-iodophenyl) nortropane (FP-CIT) positron emission tomography scans. Binding potentials (BP) at nucleus accumbens, amygdala, orbitofrontal and ventromedial prefrontal cortex (VMPFC), putamen and caudate nucleus were estimated, and whole brain parametric maps of [(18)F]-FP-CIT binding were analysed by original and putaminal normalised manners.
Results: Compared with the healthy controls, BPs at both VMPFCs were significantly high and the extrastriatal to putaminal BP ratios at all regions were approximately three times higher in both PD groups. The PD ICD patients showed significantly higher BPs at the right VMPFC and tendency to lower BPs at the left nucleus accumbens compared with those free of ICD. The ICD subjects also showed reduced uptakes at both ventral striatal regions in the original parametric analysis and higher uptakes at the left insular and right posterior cingulate cortex and lower uptakes at both ventral pallidums in the putaminal normalised parametric analysis compared with the non-ICD subjects.
Conclusions: A great gap in extrastriatal versus striatal dopaminergic fibre degenerations is an intrinsic condition predisposing to ICD in PD. Distinct pattern of extrastriatal changes between the ICD and non-ICD patients could provide a further insight into a mechanism of ICD in PD.
Keywords: Movement Disorders; Parkinson's Disease; Pet, Functional Imaging.
Similar articles
-
Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels.J Neurol Neurosurg Psychiatry. 2014 Feb;85(2):148-52. doi: 10.1136/jnnp-2013-305395. Epub 2013 Jul 30. J Neurol Neurosurg Psychiatry. 2014. PMID: 23899625 Free PMC article.
-
Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2065-2076. doi: 10.1007/s00259-019-04396-3. Epub 2019 Jul 4. Eur J Nucl Med Mol Imaging. 2019. PMID: 31273436
-
Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.J Neurol. 2015 Jun;262(6):1504-14. doi: 10.1007/s00415-015-7722-7. Epub 2015 Apr 18. J Neurol. 2015. PMID: 25893253
-
Imaging in Parkinson's disease: the role of monoamines in behavior.Biol Psychiatry. 2006 May 15;59(10):908-18. doi: 10.1016/j.biopsych.2005.12.017. Epub 2006 Apr 11. Biol Psychiatry. 2006. PMID: 16581032 Review.
-
Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.Prog Brain Res. 2010;184:177-92. doi: 10.1016/S0079-6123(10)84009-9. Prog Brain Res. 2010. PMID: 20887875 Review.
Cited by
-
Striatal DAT availability does not change after supraphysiological glucose loading dose in humans.Endocr Connect. 2021 Oct 7;10(10):1266-1272. doi: 10.1530/EC-21-0355. Endocr Connect. 2021. PMID: 34491899 Free PMC article.
-
Parkinson's disease as a system-level disorder.NPJ Parkinsons Dis. 2016 Dec 1;2:16025. doi: 10.1038/npjparkd.2016.25. eCollection 2016. NPJ Parkinsons Dis. 2016. PMID: 28725705 Free PMC article. Review.
-
Imaging Procedure and Clinical Studies of [18F]FP-CIT PET.Nucl Med Mol Imaging. 2024 Jun;58(4):185-202. doi: 10.1007/s13139-024-00840-x. Epub 2024 Jan 17. Nucl Med Mol Imaging. 2024. PMID: 38932763 Free PMC article. Review.
-
Recent advances in parametric neuroreceptor mapping with dynamic PET: basic concepts and graphical analyses.Neurosci Bull. 2014 Oct;30(5):733-54. doi: 10.1007/s12264-014-1465-9. Epub 2014 Sep 28. Neurosci Bull. 2014. PMID: 25260795 Free PMC article. Review.
-
The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling.Front Behav Neurosci. 2014 May 30;8:196. doi: 10.3389/fnbeh.2014.00196. eCollection 2014. Front Behav Neurosci. 2014. PMID: 24910600 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous